Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0020437 (
hypercalcemia
)
10,293
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
A leiomyoma of the small bowel produced laboratory features of hyperparathyroidism which disappeared promptly after tumour resection.
Hypercalcaemia
, hypophosphatemia, hyperchloremia, elevated chloride/phosphorus ratio, increased urinary cyclic AMP, and blood levels of immunoreactive
parathormone
were present. Electron microscopy showed dense round granules in the tumour cells.
...
PMID:[Leiomyoma of the small bowel with hypercalcaemia: presence of a substance with parathormone activity (author's transl)]. 53 84
A chronic
hypercalcaemia
was induced in Suncus murinus by the daily subcutaneous injections of
parathormone
for 15 days. Serum calcium increased 4 hours after the first injection (+ 0.88 mg/100 ml), it reached its highest value on day 10 (+ 2.18 mg/100 ml), and then decreased slightly at the end of the experiment (day 15). The serum phosphate level in treated animals showed a progressive fall throughout the experiment. Serial sections of thyroid-parathyroid complex were subjected to selective staining for C cells identification. The chronic
hypercalcaemia
increased the number of C cells. This was supported by the presence of mitotic figures. Degranulation of the secretory material was observed as the result of the chronic
hypercalcaemia
; degenerative changes were found in some C cells. The chronic
hypercalcaemia
also inhibited the activity of parathyroid "Chief-Cells" which ultimately degenerated.
...
PMID:Influence of parathormone on C cells, parathyroid glands, serum calcium and serum phosphate levels in the house shrew, Suncus murinus. 55 38
Case report of a female neonate with hypocalcemia and spasms. The cause was parathyroid insufficiency due to hyperparathroidism of the mother. The hypocalcemia was treated with a massive dose of Vitamin D; this led to a sharp rise of 25-OH-vitamin D levels in serum. The mother had kidney stones. There was
hypercalcemia
and a raised
parathormone
level. Diagnosis was confirmed by surgery. An adenoma weighing 7 g was removed.
...
PMID:[Neonatal hypocalcemia in hyperparathyroidism of the mother (author's transl)]. 55 75
The results of radio-immunoassay of
parathormone
in peripheral venous blood (using an anti-serum preferentially recognising fragments from the carboxyl-terminal pole) were compared with those of blood calcium measured on the same day in 33 cases of primary hyperparathyroidism. In the 28 patients with
hypercalcaemia
, PTH was invariably high (27 cases) or at the upper limit of normal (1 case). In the 5 patients with normal blood calcium levels, it was normal in 3 cases. It is thus important to take blood calcium levels into account in the interpretation of PTH estimation, that latter being more valid during a hypercalcaemic phase.
...
PMID:[The relationship between parathormone and calcium blood levels in primary hyperparathyroidism. Diagnostic value (authors transl)]. 60 36
The plasma
parathormone
was measured by radioimmunological determination in 23 cases of cancer with bone metastases, 8 of mammary origin. In 11 cases the plasma
parathormone
(iPTH) was less than 4 ng/ml (lower normal limit), as might be expected in view of the
hypercalcemia
. In 12 cases the iPTH was higher than 4 ng/ml, in 8 of these higher than 8 ng/ml (upper normal limit). These results are suggestive of the role of a substance analogous to
parathormone
in the genesis of the
hypercalcaemia
and peritumoral bone resorption of bone metastases of solid tumors.
...
PMID:[Radioimmunologic determination of plasma parathormone in hypercalcemia caused by cancer with osseous metastases]. 60 75
A case of
hypercalcemia
associated with documented squamous cell carcinoma of the renal pelvis without bony metastasis is reported. Pseudohyperparathyroidism was suspected strongly because of the radioimmunoassay values of
parathormone
. This was confirmed by the prompt decrease of serum calcium after removal of the neoplasm. The radiologic findings were non-specific.
...
PMID:Squamous cell carcinoma of the renal pelvis presenting with hypercalcemia. 62 97
An unusual finding of systemic calcinosis in a patient with a nonparathyroid malignant neoplasm stimulated us to do a sclinicopathologic review of similar cases at our institution in the past seven years. Of 3,268 autopsies performed from 1968 to 1975, a total of 17 cases of calcinosis were found, 11 with solid tumors and 6 with hematopoietic neoplasms. Calcinosis was most prominent in the lung, kidney, heart, and stomach and was rarely discovered prior to death. Eighty-two percent of the patients had
hypercalcemia
and 53% had associated bony metastatic disease. Corticosteroid or phosphate treatment for the
hypercalcemia
may have contributed to the tissue deposition of calcium. Significant hepatic, renal, metabolic, and pulmonary dysfunctions were also associated with this disorder. Thirty-six percent of the patients had
hypercalcemia
without skeletal involvement; tumor-produced
parathormone
-like substances may be responsible for these calcium abnormalities. Calcinosis was a significant complication of neoplastic disease in these patients and contributed to morbidity and mortality.
...
PMID:Calcinosis in nonparathyroid malignant disease: an unusual case report and clinicopathologic review of 17 cases. 62 63
A 21-year-old man suffered severe (up to 15.5 mg%) and prolonged (7 months)
hypercalcaemia
as a result of immobilisation following severe trauma. During the period of
hypercalcaemia
, plasma
parathormone
and calcitonin levels were undetectable. A study using radioactive calcium revealed a very marked increase in bone resorption, a moderate increase in accretion and virtually no intestinal absorption. Iliac biopsy revealed dense calcification front and there was no osteoid substance. This
hypercalcaemia
appeared to be due to increased bone resorption, while the synthesis of osteoid substance seemed to be insufficient to permit an equivalent increase in calcium accretion.
...
PMID:[Immobilisation hypercalcaemia. 1 case (author's transl)]. 63 83
A patient with poorly differentiated monocytic malignancy had extensive lytic lesions of bone and
hypercalcemia
. The patient's bone margins showed little evidence of osteoclast activity. Serum
parathormone
concentrations were slightly increased relative to the degree of
hypercalcemia
, consistent with impaired renal function. Serum concentrations of the relevant prostaglandins were normal. Supernatant medium from cultured tumor cells caused prominent bone resorption in vitro. The studies on this patient provide evidence that malignant cells of the monocyte-macrophage line are capable of direct bone resorption.
...
PMID:Production of bone resorbing activity in poorly differentiated monocytic malignancy. 65 6
A patient with known transitional cell carcinoma of the bladder and
hypercalcemia
was evaluated for urinary prostaglandin levels when no bone metastases or elevated
parathormone
levels could be demonstrated. Urinary levels of prostaglandin E metabolite were assessed in relation to serum and urinary calcium levels during treatment. The serum calcium levels decreased from the 13.0 mg. per cent range whenever the rpimary tumor was manipulated (transurethral resection) or when other treatments directed at the tumor were used (radiation therapy and chemotherapy). Serum and urinary calcium levels, and urinary prostaglandin E metabolite decreased when 3 gm. aspirin were given daily. These data suggest that the somewhat unusual
hypercalcemia
in our patient was caused by a prostaglandin-secreting transitional cell carcinoma. Prostaglandin-secreting tumors are reviewed herein.
...
PMID:Prostaglandin-mediated hypercalcemia in transitional cell carcinoma of the bladder. 66 Jul 46
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>